Literature DB >> 19584300

Structural changes in intermediate filament networks alter the activity of insulin-degrading enzyme.

Ying-Hao Chou1, Wen-Liang Kuo, Marsha Rich Rosner, Wei-Jen Tang, Robert D Goldman.   

Abstract

The intermediate filament (IF) protein nestin coassembles with vimentin and promotes the disassembly of these copolymers when vimentin is hyperphosphorylated during mitosis. The aim of this study is to determine the function of these nonfilamentous particles by identifying their interacting partners. In this study, we report that these disassembled vimentin/nestin complexes interact with insulin degrading enzyme (IDE). Both vimentin and nestin interact with IDE in vitro, but vimentin binds IDE with a higher affinity than nestin. Although the interaction between vimentin and IDE is enhanced by vimentin phosphorylation at Ser-55, the interaction between nestin and IDE is phosphorylation independent. Further analyses show that phosphorylated vimentin plays the dominant role in targeting IDE to the vimentin/nestin particles in vivo, while the requirement for nestin is related to its ability to promote vimentin IF disassembly. The binding of IDE to either nestin or phosphorylated vimentin regulates IDE activity differently, depending on the substrate. The insulin degradation activity of IDE is suppressed approximately 50% by either nestin or phosphorylated vimentin, while the cleavage of bradykinin-mimetic peptide by IDE is increased 2- to 3-fold. Taken together, our data demonstrate that the nestin-mediated disassembly of vimentin IFs generates a structure capable of sequestering and modulating the activity of IDE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19584300      PMCID: PMC2775012          DOI: 10.1096/fj.09-137455

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  56 in total

1.  Cell biology: skin care by keratins.

Authors:  M Bishr Omary; Nam-On Ku
Journal:  Nature       Date:  2006-05-18       Impact factor: 49.962

2.  Transitin, a nestin-like intermediate filament protein, mediates cortical localization and the lateral transport of Numb in mitotic avian neuroepithelial cells.

Authors:  Yoshio Wakamatsu; Noriko Nakamura; Ju-Ahng Lee; Gregory J Cole; Noriko Osumi
Journal:  Development       Date:  2007-05-23       Impact factor: 6.868

Review 3.  The motility and dynamic properties of intermediate filaments and their constituent proteins.

Authors:  Ying-Hao Chou; Frederick W Flitney; Lynne Chang; Melissa Mendez; Boris Grin; Robert D Goldman
Journal:  Exp Cell Res       Date:  2007-04-12       Impact factor: 3.905

Review 4.  Amyloid beta-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin.

Authors:  E Malito; R E Hulse; W-J Tang
Journal:  Cell Mol Life Sci       Date:  2008-08       Impact factor: 9.261

5.  Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism.

Authors:  Yuequan Shen; Andrzej Joachimiak; Marsha Rich Rosner; Wei-Jen Tang
Journal:  Nature       Date:  2006-10-11       Impact factor: 49.962

6.  A nestin scaffold links Cdk5/p35 signaling to oxidant-induced cell death.

Authors:  Cecilia M Sahlgren; Hanna-Mari Pallari; Tao He; Ying-Hao Chou; Robert D Goldman; John E Eriksson
Journal:  EMBO J       Date:  2006-10-12       Impact factor: 11.598

7.  A keratin cytoskeletal protein regulates protein synthesis and epithelial cell growth.

Authors:  Seyun Kim; Pauline Wong; Pierre A Coulombe
Journal:  Nature       Date:  2006-05-18       Impact factor: 49.962

8.  Immunohistochemical evidence of ubiquitous distribution of the metalloendoprotease insulin-degrading enzyme (IDE; insulysin) in human non-malignant tissues and tumor cell lines.

Authors:  Gregor Weirich; Karin Mengele; Christina Yfanti; Apostolos Gkazepis; Daniela Hellmann; Anita Welk; Cecylia Giersig; Wen-Liang Kuo; Marsha Rich Rosner; Wei-Jen Tang; Manfred Schmitt
Journal:  Biol Chem       Date:  2008-11       Impact factor: 3.915

9.  Regulation of protein degradation by insulin-degrading enzyme: analysis by small interfering RNA-mediated gene silencing.

Authors:  Janet Fawcett; Paska A Permana; Jennifer L Levy; William C Duckworth
Journal:  Arch Biochem Biophys       Date:  2007-09-29       Impact factor: 4.013

10.  Insulin degrading enzyme is a cellular receptor mediating varicella-zoster virus infection and cell-to-cell spread.

Authors:  Qingxue Li; Mir A Ali; Jeffrey I Cohen
Journal:  Cell       Date:  2006-10-20       Impact factor: 41.582

View more
  9 in total

1.  Ubiquitin is a novel substrate for human insulin-degrading enzyme.

Authors:  Luis A Ralat; Vasilios Kalas; Zhongzhou Zheng; Robert D Goldman; Tobin R Sosnick; Wei-Jen Tang
Journal:  J Mol Biol       Date:  2010-12-23       Impact factor: 5.469

Review 2.  Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus.

Authors:  Wei-Jen Tang
Journal:  Trends Endocrinol Metab       Date:  2015-12-02       Impact factor: 12.015

3.  Oxytocin Increases Neurite Length and Expression of Cytoskeletal Proteins Associated with Neuronal Growth.

Authors:  Z Lestanova; Z Bacova; A Kiss; T Havranek; V Strbak; J Bakos
Journal:  J Mol Neurosci       Date:  2015-10-16       Impact factor: 3.444

4.  Insulin-degrading enzyme binds to the nonglycosylated precursor of varicella-zoster virus gE protein found in the endoplasmic reticulum.

Authors:  J E Carpenter; W Jackson; G A de Souza; L Haarr; C Grose
Journal:  J Virol       Date:  2009-10-28       Impact factor: 5.103

5.  Conformational states and recognition of amyloidogenic peptides of human insulin-degrading enzyme.

Authors:  Lauren A McCord; Wenguang G Liang; Evan Dowdell; Vasilios Kalas; Robert J Hoey; Akiko Koide; Shohei Koide; Wei-Jen Tang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-06       Impact factor: 11.205

Review 6.  Insulin-Degrading Enzyme, an Under-Estimated Potential Target to Treat Cancer?

Authors:  Laetitia Lesire; Florence Leroux; Rebecca Deprez-Poulain; Benoit Deprez
Journal:  Cells       Date:  2022-04-05       Impact factor: 6.600

7.  GSK3-β promotes calpain-1-mediated desmin filament depolymerization and myofibril loss in atrophy.

Authors:  Dina Aweida; Inga Rudesky; Alexandra Volodin; Eitan Shimko; Shenhav Cohen
Journal:  J Cell Biol       Date:  2018-07-30       Impact factor: 10.539

Review 8.  Modulation of Insulin Sensitivity by Insulin-Degrading Enzyme.

Authors:  Carlos M González-Casimiro; Beatriz Merino; Elena Casanueva-Álvarez; Tamara Postigo-Casado; Patricia Cámara-Torres; Cristina M Fernández-Díaz; Malcolm A Leissring; Irene Cózar-Castellano; Germán Perdomo
Journal:  Biomedicines       Date:  2021-01-17

Review 9.  Breakdown of Filamentous Myofibrils by the UPS-Step by Step.

Authors:  Dina Aweida; Shenhav Cohen
Journal:  Biomolecules       Date:  2021-01-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.